EUVIMEDEUVIMED entdecken
Open Access

Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins

Anthony J Domma iD, Lauren A Henderson iD, Felicia D Goodrum iD, Nathaniel J Moorman iD, Jeremy P Kamil iD

Journal of Virology · 2023

DOI: 10.1128/jvi.00563-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Anthony J Domma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport , Shreveport, Louisiana, USA. Hauptthemen laut MEDLINE: Cytomegalovirus, Insulin Receptor Substrate Proteins, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The phosphoinositide 3-kinase (PI3K)/AKT pathway plays crucial roles in cell viability and protein synthesis and is frequently co-opted by viruses to support their replication. Although many viruses maintain high levels of AKT activity during infection, other viruses, such as vesicular stomatitis virus and human cytomegalovirus (HCMV), cause AKT to accumulate in an inactive state. To efficiently replicate, HCMV requires FoxO transcription factors to localize to the infected cell nucleus (Zhang et al. mBio 2022), a process that is antagonized by AKT. Here, we investigated how HCMV inactivates AKT to achieve this. Results from subcellular fractionation and live-cell imaging studies indicated a defect in the recruitment of AKT to membranes upon serum stimulation of HCMV-infected cells. UV-inactivated virions failed to inactivate AKT, suggesting a requirement for de novo viral gene expression. Through additional studies, we identify that UL38 (pUL38), a viral activator of mTORC1, inactivates AKT by destabilizing insulin receptor substrate-1 (IRS1), a protein that recruits PI3K to growth factor receptors. Decreased electrophoretic mobility and diminished expression of IRS1 correlated with the accumulation of UL38 protein during infection. However, destabilization of IRS1 and loss of AKT activity did not occur in cells infected with an HCMV mutant disrupted for UL38 nor when mTORC1 was inhibited by rapamycin. Finally, ectopic expression of UL38 in uninfected cells sufficed to cause IRS1 degradation and AKT inactivation, and these effects were likewise reversed by rapamycin. Collectively, our results demonstrate that HCMV relies upon a cell-intrinsic negative feedback loop to render AKT inactive during productive infection. IMPORTANCE Human cytomegalovirus (HCMV) requires inactivation of AKT to efficiently replicate, yet how AKT is shut off during HCMV infection has remained unclear. We show that UL38, an HCMV protein that activates mTORC1, is necessary and sufficient to destabilize insulin receptor substrate 1 (IRS1), a model insulin receptor substrate (IRS) protein. Degradation of IRS proteins in settings of excessive mTORC1 activity is an important mechanism for insulin resistance. When IRS proteins are destabilized, PI3K cannot be recruited to growth factor receptor complexes, and hence, AKT membrane recruitment, a rate limiting step in its activation, fails to occur. Despite its penchant for remodeling host cell signaling pathways, our results reveal that HCMV relies upon a cell-intrinsic negative regulatory feedback loop to inactivate AKT. Given that pharmacological inhibition of PI3K/AKT potently induces HCMV reactivation from latency, our findings also imply that the expression of UL38 activity must be tightly regulated within latently infected cells to avoid spontaneous reactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusInsulin Receptor Substrate ProteinsProto-Oncogene Proteins c-aktHumansMechanistic Target of Rapamycin Complex 1Phosphatidylinositol 3-KinasesProtein StabilityProteolysisInsulin ResistanceFeedback, PhysiologicalVirus ActivationVirus LatencyCapsid Proteins

Stichwörter der Autor:innen

AKTIRSPI3Kcell signalingcytomegalovirusherpesvirusinsulinkinasesmTORmTORC1

Substanzen

Insulin Receptor Substrate ProteinsMechanistic Target of Rapamycin Complex 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktUL38 protein, human herpesvirus-5Capsid Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport , Shreveport, Louisiana, USA.
  • Department of Immunobiology, University of Arizona , Tucson, Arizona, USA.
  • Bio5 Institute, University of Arizona , Tucson, Arizona, USA.
  • Department of Microbiology and Immunology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina, USA.

ORCID-Profile: Anthony J Domma, Lauren A Henderson, Felicia D Goodrum, Nathaniel J Moorman, Jeremy P Kamil

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | National Institute of General Medical Sciences

Zitieren

APA

Domma, A. J., Henderson, L. A., Goodrum, F. D., Moorman, N. J., & Kamil, J. P. (2023). Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins. Journal of Virology. https://doi.org/10.1128/jvi.00563-23

Vancouver

Domma AJ, Henderson LA, Goodrum FD, Moorman NJ, Kamil JP. Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins. Journal of Virology. 2023. doi:10.1128/jvi.00563-23

BibTeX
@article{Domma2023,
  author = {Domma, Anthony J and Henderson, Lauren A and Goodrum, Felicia D and Moorman, Nathaniel J and Kamil, Jeremy P},
  title = {Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins},
  journal = {Journal of Virology},
  year = {2023},
  doi = {10.1128/jvi.00563-23}
}
Kostenlos starten →